anika-therapeutics.jpgA worldwide development and commercialization agreement was signed between Anika Therapeutics Inc, of Woburn and Galderma Pharma S.A. a joint venture between Nestle and L’Oreal, for cosmetic tissue augmentation therapies, used in to correct facial wrinkles, scar remediation and lip augmentation. The initial products are set to be released out in mid-2007.